ARCHIVES

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

April 20, 2007

Klausner Unveils New NCI Structure, Aims To Change Institute’s “Ethos”

August 11, 1995

In Brief: AC Committee Picks Seffrin for Executive VP; Charles Wilson Names to NCAB; 5 Leave Board

May 15, 1992

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

July 29, 2005

NCAB Seeks Greater flexibility In Grants Target To Aid P01s

May 31, 1991

In Brief: White House Conservative Said Seeking Ouster Of Schweiker; Potter urges Greater Commitment

November 26, 1982